You will be redirected to:
Paris 9th January, 2023 (France) - Today, EvidentIQ, a leading clinical data science group and Keyrus Life Science, the international Connected Contract Research Organization (C²RO), announced the signing of a strategic partnership. The synergy between both companies will improve automation, efficiency and agility in clinical research by leveraging new eClinical capabilities.
EvidentIQ, based in Hamburg, is a leading clinical data science group, offering state-of-the art eClinical solutions (eConsent, EDC, CTMS, eCOA, RWE).
Keyrus Life Science, operating across Europe and North America, connects CRO expertise, life data science and digital enablement to fully leverage both clinical research ecosystems and real-world evidence to help organizations shape better their clinical research trial strategies.
“I’m very proud to be able to announce today the formation of a strategic partnership between EvidentIQ and Keyrus Life Science. I strongly believe that it will transform the industry and create significant value for our customers as they will benefit from receiving industry leading eClinical technology, Real World Evidence and a world-class, full service model on one hand.” says Andreas Weber, CEO at EvidentIQ.
“Thanks to this partnership, Keyrus Life Science and EvidentIQ will be able to digitally empower and operate clinical research on a new level, offering life science companies the capability to access enhanced reactivity, flexibility and get the full value from their data in the development of new drugs and therapies” states Michael Attlan, VP Life Science at Keyrus, “This synergy and the complementary offerings between our two companies are both key success factors in delivering practical and efficient solutions for our clients in clinical research”.
Stay updated on the latest articles, events, and more
Blog post
Nowadays, all companies active in the life science ecosystem consider data as a crucial asset to their success. Pharma companies are collecting more and more information during their clinical trials or commercial and medical activities. Clinical laboratories have to deploy complex data infrastructures to better serve their patients and clients, and Biotech and MedTech companies need to gather and analyze a lot of scientific and technical data.
Press release
Paris, Levallois-Perret, November 7th, 2022 - Keyrus Life Science and Parean Biotechnologies will join their expertise in data science and technologies to meet the most critical challenges for clients in the fields of biometry, biostatistics and bioinformatics.
Event
This summer was very busy and interesting for the Keyrus Life Science North America Team. We attended three pivotal life science conferences: Decentralized Clinical Trials Conference, BIO International Convention, and DIA Conference.
Press release
Paris, Levallois-Perret, June 23, 2022 - Keyrus Life Science announces the launch of its new visual identity strengthening its synergies with the Keyrus Group to address the most pressing challenges of its clients in the life science industry and to drive clinical research forward.
Expert's opinion
Digitalization, data and connectivity has become part of our daily lives in all its dimensions.
Expert's opinion
Clinical trials produce a massive amount of data. In most cases, the challenge lies less in the volume of data to process, but more in its diversity. The sources of data are indeed numerous and do not stop increasing.
Blog post
The World Heart Day, an occasion to remind us all, that cardiovascular diseases (CVD) causes more than 18 million of deaths per year.
Event
Today, September 21st, is the World Alzheimer’s Day, so let’s do a quick review of the investigated therapeutic targets to find a cure to this pathology
Event
Keyrus Life Science joined the Keyrus Foundation in the team sports challenge 'Connected against hunger'
Blog post
We are happy to have partnered with European Centre for Clinical Research Training (ECCRT) in training our experts at Keyrus Life Science.